Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Cancer

Retrieve available abstracts of 21 articles:
HTML format

Single Articles

    December 2022
  1. FREY MK, Ahsan MD, Badiner N, Lin J, et al
    What happens in the long term: Uptake of cancer surveillance and prevention strategies among at-risk relatives with pathogenic variants detected via cascade testing.
    Cancer. 2022;128:4241-4250.
    PubMed     Abstract available

    May 2022
  2. LOKE J, Labopin M, Craddock C, Cornelissen JJ, et al
    Additional cytogenetic features determines outcome in patients allografted for TP53 mutant acute myeloid leukemia.
    Cancer. 2022 May 25. doi: 10.1002/cncr.34268.
    PubMed     Abstract available

    April 2022
  3. REIZINE NM, Danahey K, Truong TM, George D, et al
    Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing.
    Cancer. 2022;128:1649-1657.
    PubMed     Abstract available

  4. STADLER WM, Hlubocky FJ, Hathaway F
    Knowledge and distress in complex cancer care.
    Cancer. 2022;128:1359-1360.

    February 2022
  5. OSAKO T, Matsuura M, Yotsumoto D, Takayama S, et al
    A prediction model for early systemic recurrence in breast cancer using a molecular diagnostic analysis of sentinel lymph nodes: A large-scale, multicenter cohort study.
    Cancer. 2022 Feb 28. doi: 10.1002/cncr.34144.
    PubMed     Abstract available

  6. KISIEL JB, Papadopoulos N, Liu MC, Crosby D, et al
    Multicancer early detection test: Preclinical, translational, and clinical evidence-generation plan and provocative questions.
    Cancer. 2022;128 Suppl 4:861-874.
    PubMed     Abstract available

  7. CROWDER SL, Hoogland AI, Welniak TL, LaFranchise EA, et al
    Metagenomics and chemotherapy-induced nausea: A roadmap for future research.
    Cancer. 2022;128:461-470.
    PubMed     Abstract available

    January 2022
  8. ARUN BK, Peterson SK, Sweeney LE, Bluebond RD, et al
    Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.
    Cancer. 2022;128:94-102.
    PubMed     Abstract available

    October 2021
  9. PINATTI LM, Gu W, Wang Y, Elhossiny A, et al
    SearcHPV: A novel approach to identify and assemble human papillomavirus-host genomic integration events in cancer.
    Cancer. 2021;127:3531-3540.
    PubMed     Abstract available

    August 2021
  10. HENDERSON V, Ganschow P, Wang C, Hoskins KF, et al
    Population screening to identify women at risk for hereditary breast cancer syndromes: The path forward or the road not taken?
    Cancer. 2021 Aug 23. doi: 10.1002/cncr.33867.

  11. NECCHI A, Cucchiara V, Grivas P, Bratslavsky G, et al
    Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer.
    Cancer. 2021 Aug 11. doi: 10.1002/cncr.33865.
    PubMed     Abstract available

  12. SCHRANK TP, Lenze N, Landess LP, Hoyle A, et al
    Genomic heterogeneity and copy number variant burden are associated with poor recurrence-free survival and 11q loss in human papillomavirus-positive squamous cell carcinoma of the oropharynx.
    Cancer. 2021;127:2788-2800.
    PubMed     Abstract available

    April 2021
  13. URICK ME, Yu EJ, Bell DW
    High-risk endometrial cancer proteomic profiling reveals that FBXW7 mutation alters L1CAM and TGM2 protein levels.
    Cancer. 2021 Apr 19. doi: 10.1002/cncr.33567.
    PubMed     Abstract available

  14. CULVER JO, Ricker CN, Bonner J, Kidd J, et al
    Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients.
    Cancer. 2021;127:1275-1285.
    PubMed     Abstract available

  15. PARK S, Olsen S, Ku BM, Lee MS, et al
    High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean lung liquid versus invasive biopsy program.
    Cancer. 2021 Apr 7. doi: 10.1002/cncr.33571.
    PubMed     Abstract available

  16. PRINTZ C
    First person profile: Matthew L. Meyerson, MD, PhD: Pioneering scientist leads key discoveries in cancer genomics.
    Cancer. 2021;127:991-993.

  17. HENDERSON V, Chukwudozie IB, Comer-Hagans D, Coffey V, et al
    Development of a culturally sensitive narrative intervention to promote genetic counseling among African American women at risk for hereditary breast cancer.
    Cancer. 2021 Apr 1. doi: 10.1002/cncr.33525.
    PubMed     Abstract available

    October 2020
  18. YIN K, Singh P, Drohan B, Hughes KS, et al
    Breast imaging, breast surgery, and cancer genetics in the age of COVID-19.
    Cancer. 2020;126:4466-4472.
    PubMed     Abstract available

    June 2020
  19. IBRAHEEM A, Olopade OI, Huo D
    Propensity score analysis of the prognostic value of genomic assays for breast cancer in diverse populations using the National Cancer Data Base.
    Cancer. 2020 Jun 10. doi: 10.1002/cncr.32956.
    PubMed     Abstract available

  20. DANCIU OC, Chen Z, Hoskins KF
    If you don't measure it, you can't improve it: Success and shortcomings of genomic assays in early breast cancer.
    Cancer. 2020 Jun 10. doi: 10.1002/cncr.32955.

    March 2020
  21. PASSARO A, Malapelle U, Attili I, de Marinis F, et al
    Overcoming resistance to osimertinib in non-small cell lung cancer: Hopes, doubts, and in-between.
    Cancer. 2020 Mar 10. doi: 10.1002/cncr.32810.

Thank you for your interest in scientific medicine.

AMEDEO Genetics is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.